Market Overview:
Pediatric
clinical trials are generally designed and carried out with little children in
mind. As with medical research with adults, however, it starts with a standard
protocol and careful plan of study activities. But a pediatric clinical trial
is also designed specifically with certain specific considerations in mind for
children. Age, health, and symptoms of the child are among the most important
considerations when determining which trials to conduct. For infants, age is one of the main special
considerations. Some clinical studies are only done on children as young as six
weeks old. Because of this, parents should be made aware of the need to enroll
their infant in any pediatric clinical trials. Special care should also be
given to those with special needs, such as premature infants or very young
children who are at higher risk of developing certain diseases. All these
considerations must be taken into consideration before administering any
medications to a child.
Key Market Drivers:
The
increasing prevalence of pediatricians in the world is expected to augment the
growth of the global pediatric clinical trials market. For instance, according
to the American Academy of Pediatrics, there are more than 3810 pediatricians
in the United States currently. Most pediatric clinical trials are conducted on
healthy children who don't have any history of disease or other illness that
might affect the drug. The drugs are typically administered by intramuscular or
subcutaneous injection. But sometimes, intramuscular injections are not
suitable, especially in very sick children or those with other health problems.
Thus, it is necessary to carry out a trial that uses an aerosol spray. The high
introduction of pediatric trials is estimated to enhance the growth of the
global pediatric clinical trials market.
Covid-19 Impact Analysis:
During
the COVID-19 pandemic, there was a boost in the number of clinical trials,
which drove the growth in the global pediatric clinical trials market. There
were some major developments in the market. For instance, in June 2020,
Leukemia & Lymphoma Society (LLS) partnered with Children’s Oncology Group
(COG) and National Cancer Institute (NCI) in order to launch a precision
medicine for clinical trials related to children suffering from acute leukemia.
Key Takeaways:
·
North
America is expected to dominate the growth of the global pediatric clinical
trials market, owing to the increasing prevalence of key players in the region.
For instance, in March 2021, Moderna Inc. announced the first participants
dosed in Phase 2 of COVID-19 vaccine trials among the pediatric population.
·
The
Asia Pacific is estimated to witness high growth in the global pediatric
clinical trials market, owing to the high birth rate in the region. For
instance, according to the United Nations International Children's Emergency
Fund, around 25 million children are born every year in India.

Comments
Post a Comment